• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Bionomics Limited - Articles and news items

depression-BNC210

Bionomics initiates Phase II clinical study of BNC210 for the treatment of anxiety and depression

Industry news / 22 April 2015 / Victoria White

Bionomics has initiated a Phase II clinical study of BNC210, the Company’s drug candidate in development for the treatment of anxiety and depression…

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +